icon-folder.gif   Conference Reports for NATAP  
 
  17th European AIDS Conference
November 6-9
2019, Basel
Back grey_arrow_rt.gif
 
 
 
ASSESSMENTS OF VERY-LOW-LEVEL HIV REPLICATION FOR DOLUTEGRAVIR + LAMIVUDINE (DTG + 3TC) VS DOLUTEGRAVIR + TENOFOVIR DISOPROXIL/EMTRICITABINE (DTG + TDF/FTC) IN THE GEMINI-1&-2 STUDIES THROUGH WEEK 96
 
 
  17th EACS 2019 Nov 6-9 Basel
Reported by Jules Levin
 
Mark Underwood,1 Rimgaile Urbaityte,2 Ruolan Wang,1 Allan Tenorio,1 Brian Wynne,1 Keith Pappa,1 Justin Koteff,1 Martin Gartland,1 Jean van Wyk,3 Choy Man,1 Jörg Sievers3
 
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline, Stockley Park, UK; 3ViiV Healthcare, Brentford, UK

1108191

1108192

1108193

1108194

1108195